Eye News and Research

Latest Eye News and Research

Brigham and Women's Hospital study examines sustained inattentional blindness in expert observers

If you were working on something at your computer and a gorilla floated across your computer screen, would you notice it? You would like to think yes, however, research shows that people often miss such events when engaged in a difficult task.

20 Jul 2013

Viewpoints: Expanding abortion restrictions; Lift the ban on gay blood donors; Medicare's price schedules

What's going on in Wisconsin, North Dakota, South Dakota and Iowa ought to be a wake-up call to Minnesotans who prefer that physicians, not politicians, guide an individual's medical care. Minnesota's neighbors have moved with alarming alacrity to cripple women's access to a safe and legal medical procedure -; abortion (7/18).

20 Jul 2013

Investigators report complete catalog of genes expressed in retina

Investigators at Massachusetts Eye and Ear and Harvard Medical School have published the most thorough description of gene expression in the human retina reported to date. In a study published today in the journal BMC Genomics, Drs. Michael Farkas, Eric Pierce and colleagues in the Ocular Genomics Institute at Mass. Eye and Ear reported a complete catalog of the genes expressed in the retina.

20 Jul 2013

IVAN study: Lucentis and Avastin effective in treating wet AMD

An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness in older adults as a more expensive drug specifically formulated for this purpose.

20 Jul 2013

Oxytocin may not improve symptoms of children with autism, study finds

The so-called trust hormone, oxytocin, may not improve the symptoms of children with autism, a large study led by researchers at the University of New South Wales has found.

19 Jul 2013

Bausch + Lomb obtains option to license MIM-D3 for treatment of dry eye syndrome

Bausch + Lomb, the global eye health company, and Mimetogen Pharmaceuticals Inc. today announced that Bausch + Lomb has acquired an option to license an investigational compound currently in Phase 2 development for the treatment of dry eye syndrome, a condition that affects millions of people worldwide.

19 Jul 2013

Creating, promoting foods containing angiogenesis is the new frontier in dietary health

Creating and promoting foods that contain natural inhibitors of unhealthy angiogenesis - the formation of blood vessels that feed and promote disease, obesity and inflammation - is the "new frontier in dietary health," according to a presentation at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- in Chicago.

18 Jul 2013

Pioneer ACO results include improved quality, lowered Medicare costs

Even with these marks, nine of the health systems -- nearly a third of those participating in the program -- have decided to leave after the first year.

18 Jul 2013

Cost of emergency room visits for severe dizziness projected to reach $4.4 billion by 2015

A new Johns Hopkins research report says emergency room visits for severe dizziness have grown exponentially in recent years, with costs topping $3.9 billion in 2011 and projected to reach $4.4 billion by 2015.

18 Jul 2013

Seafood provides essential nutrients but consumers still keep watchful eye on safety

Seafood continues to be a proven strong nutrient-rich food providing essential vitamins, minerals and omega-3 fatty acids, but consumers and some toxicologists still keep a watchful eye on safety, according to a July 16 panel discussion at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Food Expo- held at McCormick Place.

18 Jul 2013

Researchers discover new protein that encourages ‘bad’ blood vessel growth

The discovery of a protein that encourages blood vessel growth, and especially 'bad' blood vessels - the kind that characterise diseases as diverse as cancer, age-related macular degeneration and rheumatoid arthritis - has been reported in the journal Nature.

18 Jul 2013

U.S. news issues its hospital honor roll

This year's rankings cover nearly 5,000 medical centers across the country and span 16 medical specialties.

17 Jul 2013

Pre-diabetic patients who have substantial weight loss reduce their risk of type II diabetes

People with pre-diabetes who lose roughly 10 percent of their body weight within six months of diagnosis dramatically reduce their risk of developing type 2 diabetes over the next three years, according to results of research led by Johns Hopkins scientists.

17 Jul 2013

Weill Cornell reports new findings from IVIG Phase 3 trial in Alzheimer's disease at AAIC 2013

Weill Cornell Medical College neurologist Dr. Norman Relkin reported new findings today from the Phase 3 clinical trial of IVIG (intravenous immunoglobulin) in mild to moderate Alzheimer's disease at the Alzheimer's Association International Conference in Boston, Mass.

16 Jul 2013

Insurers could be caught in health law's smoker glitch; Student health plans to get an upgrade

As the health overhaul's implementation marches on, the Obama administration has limited a provision relating to the cost of smokers' premiums and one news outlet looks at the effects on plans available to college students.

16 Jul 2013

Comprehensive guide for clinicians to treat medical complications of bulimia

A new study in Eating Disorders: The Journal of Treatment & Prevention identifies the numerous medical problems associated with bulimia and provides comprehensive information on diagnosis and treatment for clinicians in various arms of medicine.

16 Jul 2013

USC study shows missing brain protein may be responsible for severe over-worry and fear

A little bit of learned fear is a good thing, keeping us from making risky, stupid decisions or falling over and over again into the same trap. But new research from neuroscientists and molecular biologists at USC shows that a missing brain protein may be the culprit in cases of severe over-worry, where the fear perseveres even when there's nothing of which to be afraid.

16 Jul 2013

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women.

16 Jul 2013

Genetic abnormality linked to cancer four times more common in people with type 2 diabetes

A type of genetic abnormality linked to cancer is more common in people with type 2 diabetes than the rest of the population, a new study has found.

15 Jul 2013

Most patients willing to donate eyes for research, but few do

Far more people are willing to donate their eyes to research than actually are registered to donate, according to a study led by a Michigan State University student.

15 Jul 2013

Eye News and Research

Latest Eye News and Research

Brigham and Women's Hospital study examines sustained inattentional blindness in expert observers

Viewpoints: Expanding abortion restrictions; Lift the ban on gay blood donors; Medicare's price schedules

Investigators report complete catalog of genes expressed in retina

IVAN study: Lucentis and Avastin effective in treating wet AMD

Oxytocin may not improve symptoms of children with autism, study finds

Bausch + Lomb obtains option to license MIM-D3 for treatment of dry eye syndrome

Creating, promoting foods containing angiogenesis is the new frontier in dietary health

Pioneer ACO results include improved quality, lowered Medicare costs

Cost of emergency room visits for severe dizziness projected to reach $4.4 billion by 2015

Seafood provides essential nutrients but consumers still keep watchful eye on safety

Researchers discover new protein that encourages ‘bad’ blood vessel growth

U.S. news issues its hospital honor roll

Pre-diabetic patients who have substantial weight loss reduce their risk of type II diabetes

Weill Cornell reports new findings from IVIG Phase 3 trial in Alzheimer's disease at AAIC 2013

Insurers could be caught in health law's smoker glitch; Student health plans to get an upgrade

Comprehensive guide for clinicians to treat medical complications of bulimia

USC study shows missing brain protein may be responsible for severe over-worry and fear

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Genetic abnormality linked to cancer four times more common in people with type 2 diabetes

Most patients willing to donate eyes for research, but few do

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye News and Research

Latest Eye News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in